No effect of omega-3 fatty acids and vitamine D supplements on incident AF

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
ESC Congress 2024
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
- Manesh R. Patel, MD, FACC, FAHA, FSCAI
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
AHA 2023
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
- Christian Ruff, MD
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
ESC Congress 2023
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
- Amy Groenewegen, MD
Unexpected results after switching from VKA to DOAC in frail older patients with AF
Unexpected results after switching from VKA to DOAC in frail older patients with AF
ESC Congress 2023
Unexpected results after switching from VKA to DOAC in frail older patients with AF
- Linda Joosten, MD